Oscar Health, Inc. (NYSE:OSCR) Q4 2023 Earnings Conference Call February 7, 2024 5:00 PM ET
Company Participants
Chris Potochar - VP, Treasury & IR
Mark Bertolini - CEO
Scott Blackley - CFO
Conference Call Participants
Adam Ron - Bank of America
Josh Raskin - Nephron Research
Nathan Rich - Goldman Sachs
Stephen Baxter - Wells Fargo
Adam Ron - Bank of America
Operator
Good morning. My name is Bhavesh [ph], and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]
Thank you. I will now turn the conference over to Chris Potochar, Vice President of Treasury and Investor Relations.
Chris Potochar
Good evening, everyone. Thank you for joining us for our fourth quarter and full year 2023 earnings call. Mark Bertolini, Oscar's Chief Executive Officer; and Scott Blackley, Oscar's Chief Financial Officer, will host this evening’s call.
This call can also be accessed through our Investor Relations website at ir.hioscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our Investor Relations website at ir.hioscar.com.
Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our quarterly report on Form 10-Q for the quarterly period ended September 30, 2023, filed with the SEC and other filings with the SEC, including our annual report on Form 10-K for the period ended December 31, 2023, to be filed with the SEC. Such forward-looking statements are based on current expectations as of today. Oscar anticipates that subsequent events and developments may cause estimates to change. While the company may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so.
The call will also refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in the fourth quarter and full year 2023 earnings press release, available on the company's Investor Relations website at ir.hioscar.com.